XML 88 R59.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Subsequent Event (Details) $ in Millions | Apr. 19, 2024 USD ($) contract | Apr. 05, 2024 USD ($) | Sep. 15, 2023 USD ($) | Mar. 15, 2023 USD ($) | Feb. 02, 2022 USD ($) | Mar. 31, 2024 USD ($)
--- | --- | --- | --- | --- | --- | ---
Line of Credit |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Draw on credit facility |  |  | $ 5.0 | $ 5.0 | $ 20.0 |
Credit facility, aggregate principal amount |  |  |  |  |  | $ 75.0
Subsequent Event |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Net proceeds | $ 39.8 |  |  |  |  |
Preferred stock purchased |  | $ 3.0 |  |  |  |
Subsequent Event | Pharmakon Credit Facility | Line of Credit |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Potential additional tranches | contract | 3 |  |  |  |  |
Tranches with minimum net sales milestones | contract | 2 |  |  |  |  |
Subsequent Event | Pharmakon Credit Facility | Line of Credit | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Basis spread on variable rate | 6.75% |  |  |  |  |
Interest rate floor | 3.75% |  |  |  |  |
Subsequent Event | Pharmakon Credit Facility, Tranche One | Line of Credit |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Draw on credit facility | $ 75.0 |  |  |  |  |
Subsequent Event | Pharmakon Credit Facility, Tranche Two | Line of Credit |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Credit facility, aggregate principal amount | 25.0 |  |  |  |  |
Subsequent Event | Pharmakon Credit Facility, Tranche Three | Line of Credit |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Credit facility, aggregate principal amount | 50.0 |  |  |  |  |
Subsequent Event | Pharmakon Credit Facility, Tranche Four | Line of Credit |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Credit facility, aggregate principal amount | $ 50.0 |  |  |  |  |

X
- Definition Debt Instrument, Floor Interest Rate + References No definition available. + Details
Name: | tars_DebtInstrumentFloorInterestRate
Namespace Prefix: | tars_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Debt Instrument, Number Of Potential Additional Tranches + References No definition available. + Details
Name: | tars_DebtInstrumentNumberOfPotentialAdditionalTranches
Namespace Prefix: | tars_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Debt Instrument, Number Of Tranches With Milestone Requirements + References No definition available. + Details
Name: | tars_DebtInstrumentNumberOfTranchesWithMilestoneRequirements
Namespace Prefix: | tars_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage points added to the reference rate to compute the variable rate on the debt instrument. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of cash outflow to acquire investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as investing activity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 19 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-19 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 45 -Paragraph 1 -SubTopic 10 -Topic 321 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479567/321-10-45-1 + Details
Name: | us-gaap_PaymentsToAcquireEquitySecuritiesFvNi
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(f)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromLinesOfCredit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings. + References No definition available. + Details
Name: | us-gaap_ProceedsFromRepaymentsOfDebt
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=tars_PharmakonCreditFacilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=tars_PharmakonCreditFacilityTrancheOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=tars_PharmakonCreditFacilityTrancheTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=tars_PharmakonCreditFacilityTrancheThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DebtInstrumentAxis=tars_PharmakonCreditFacilityTrancheFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |